We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-1.04%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.6B
AUM Growth
-$2.31B
(-5.8%)
Cap. Flow
-$309M
Cap. Flow
% of AUM
-0.82%
Top 10 Holdings %
Top 10 Hldgs %
14.09%
Holding
3,035
New
443
Increased
1,011
Reduced
1,232
Closed
320
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$465M |
| 2 |
Amazon
AMZN
|
+$304M |
| 3 |
Apple
AAPL
|
+$297M |
| 4 |
Occidental Petroleum
OXY
|
+$286M |
| 5 |
Zoom
ZM
|
+$259M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$395M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$373M |
| 3 |
Caterpillar
CAT
|
+$297M |
| 4 |
Intel
INTC
|
+$277M |
| 5 |
NVIDIA
NVDA
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.58% |
| 2 | Healthcare | 20.45% |
| 3 | Consumer Discretionary | 10.84% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
2101
DELISTED
Cymabay Therapeutics
CBAY
| $395K | ﹤0.01% |
127,038
-60,100
| -32% | -$189K |
|
|
HIBB
2102
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $395K | ﹤0.01% |
+8,900
| New | +$482K |
|
2103
Stoke Therapeutics
STOK
$1.8B
| $394K | ﹤0.01% |
18,700
-21,300
| -53% | -$427K |
|
|
OSG
2104
Octave Specialty Group
OSG
$243M
| $389K | ﹤0.01% |
37,400
+2,700
| +8% | +$36.6K |
|
2105
Savara
SVRA
$1.12B
| $389K | ﹤0.01% |
296,715
-466,400
| -61% | -$562K |
|
2106
The Ensign Group
ENSG
$10.4B
| $387K | ﹤0.01% |
4,300
+1,600
| +59% | +$130K |
|
2107
Gerdau
GGB
$9.74B
| $386K | ﹤0.01% |
75,600
+18,648
| +33% | +$80.1K |
|
|
SCU
2108
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $386K | ﹤0.01% |
27,700
-52,700
| -66% | -$853K |
|
2109
Genesco
GCO
$425M
| $385K | ﹤0.01% |
+6,054
| New | +$394K |
|
|
BRKL
2110
DELISTED
Brookline Bancorp
BRKL
| $384K | ﹤0.01% |
24,300
+1,500
| +7% | +$25.3K |
|
2111
CEL-SCI Corp
CVM
$20.3M
| $383K | ﹤0.01% |
3,247
+2,170
| +201% | +$353K |
|
2112
Anavex Life Sciences
AVXL
$255M
| $382K | ﹤0.01% |
+31,000
| New | +$381K |
|
2113
Prosperity Bancshares
PB
$8.97B
| $382K | ﹤0.01% |
+5,500
| New | +$405K |
|
|
CFLT
2114
DELISTED
Confluent
CFLT
| $381K | ﹤0.01% |
9,300
+5,300
| +133% | +$276K |
|
2115
Douglas Emmett
DEI
$1.98B
| $381K | ﹤0.01% |
+11,400
| New | +$374K |
|
|
HAYN
2116
DELISTED
Haynes International, Inc.
HAYN
| $381K | ﹤0.01% |
8,954
-4,500
| -33% | -$177K |
|
|
APTX
2117
DELISTED
Aptinyx Inc. Common Stock
APTX
| $379K | ﹤0.01% |
167,100
-33,700
| -17% | -$101K |
|
2118
Federal Realty Investment Trust
FRT
$10.7B
| $378K | ﹤0.01% |
+3,100
| New | +$382K |
|
2119
Hanmi Financial
HAFC
$945M
| $378K | ﹤0.01% |
15,342
-11,500
| -43% | -$296K |
|
2120
Rackspace Technology
RXT
$1.05B
| $378K | ﹤0.01% |
+33,900
| New | +$401K |
|
|
PPL
2121
PPL Corp
PPL
$26.5B
| $377K | ﹤0.01% |
13,200
-331,600
| -96% | -$9.35M |
|
2122
Simulations Plus
SLP
$369M
| $377K | ﹤0.01% |
7,400
-9,000
| -55% | -$386K |
|
|
UBX
2123
DELISTED
Unity Biotechnology
UBX
| $376K | ﹤0.01% |
33,590
-18,680
| -36% | -$210K |
|
2124
Cabaletta Bio
CABA
$437M
| $374K | ﹤0.01% |
184,100
+106,000
| +136% | +$277K |
|
2125
Distribution Solutions Group
DSGR
$1.6B
| $374K | ﹤0.01% |
+19,400
| New | +$422K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, Two Sigma Advisers held 3,035 positions worth $37.6B, down 5.8% from $39.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers's Q1 2022 filing shows 443 new, 1,011 increased, 1,232 reduced and 320 closed positions. Its largest new stake was PepsiCo: 1,100,300 shares worth $184M. The largest sale was Coca-Cola, an estimated $395M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Two Sigma Advisers's largest Q1 2022 buy was PepsiCo: 1,100,300 shares worth $184M.
- Two Sigma Advisers added most to Adobe in Q1 2022, an estimated $465M increase.
- Two Sigma Advisers's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $395M.
- Two Sigma Advisers fully exited Activision Blizzard in Q1 2022, selling an estimated $373M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $37.6B portfolio in Q1 2022.
- Two Sigma Advisers opened 443 new positions and closed 320 in Q1 2022.
- Two Sigma Advisers's portfolio value fell 5.8% quarter-over-quarter to $37.6B.
Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.